Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International

Wikipedia Affiliate Button

Home > Press > Nanobiosym CEO Dr. Anita Goel and Former UK PM Tony Blair Tackle Global Challenges at Novartis Forum

Abstract:
Nanobiosym® Chairman and CEO Dr. Anita Goel, MD, PhD and Former UK Prime Minister Tony Blair delivered keynote addresses at the annual Novartis Forum for Excellence in Spain on June 2, 2011. Mr. Blair outlined five key challenges facing our planet today, while Dr. Goel unveiled game-changing nanotechnology solutions in development by Nanobiosym to address the most pressing global challenges in healthcare, energy and the environment.

Nanobiosym CEO Dr. Anita Goel and Former UK PM Tony Blair Tackle Global Challenges at Novartis Forum

Madrid, Spain | Posted on June 8th, 2011

The Novartis Forum for Excellence exemplifies the Novartis commitment to research, development, and commercialization of innovation and excellence in business. According to Francisco Ballester, CEO of Novartis Pharmaceuticals, "Innovation and commitment will always come with leadership. These leaders have a visionary, different attitude and ideas that shine." Times of great uncertainty demand leaders that can articulate a clear vision for the future. One that defines us, unites us and inspires us. This fourth Novartis forum was held in the framework of ExpoManagement, the largest management conference in Spain where elite business leaders gather to discuss the latest challenges and innovations in science, technology and social responsibility.

Considered one of the world's most influential global leaders, Mr. Blair addressed the key challenges facing the world today, including, managing the new interdependent global economy, energy supply security, peace in the Middle East, a new direction for Europe and the emergence of China. Mr. Blair highlighted the need for leadership in science and technology to accelerate sustainable development across the globe.

One of the world's top science and technology innovators, Dr. Anita Goel showcased nanotechnology-enabled solutions that she and Nanobiosym are developing to address some of the most pressing global challenges. A Harvard-MIT trained physicist and physician, and an internationally recognized nanotechnology expert and entrepreneur, Dr. Goel unveiled some of Nanobiosym's breakthrough technologies like Gene-RADAR®, a nanotechnology device platform that reduces the infrastructure required for diagnosing diseases from a centralized pathology lab to a mobile device much like a cellphone. She invited the audience to join the Nanobiosym Global Innovation Ecosystem to help scale up these game-changing technologies and collectively tackle the largest problems facing our planet today. "I believe that science and technology alone, no matter how game-changing, are not enough. We need to raise the consciousness with which we deploy these technologies across the globe." She also outlined a roadmap to harness nanotechnology to drive the new global economy defining key leadership roles that Europe and the United States, as well as emerging economies can play.

Inspired by the underlying unity of nature, Dr. Goel embarked upon a quest over 15 years ago to bring the worlds of physics and biomedicine together using nanotechnology - the ability to probe and control nature at very small scales- less than a billionth of a meter. "We already have the tools within science and technology to address many of the world's problems today such as access to healthcare, sustainable supplies of energy, food and water." Dr. Goel urged the need for a more holistic approach that transcends the conventional boundaries between various fields of science, technology, industries and geopolitics, enabling new quantum leaps in how we solve global problems.

####

About Nanobiosym
Nanobiosym® (NBS) is an innovation engine dedicated to creating a new science that emerges from the holistic integration of physics, biomedicine, and nanotechnology. NBS focuses on incubating transformational technologies that have the potential for game-changing impact and commercializing and scaling up these technologies for deployment in developed and developing world markets. NBS leverages science and technology to address our planet’s greatest unmet needs in global health, energy and the environment. Nanobiosym® Diagnostics (NBSDx) focuses on the commercialization of the Gene-RADAR®, a portable nanotechnology platform that can rapidly and accurately detect genetic fingerprints from any biological organism, empowering people worldwide with rapid, affordable, and portable diagnostic information about their own health.To maximize global humanitarian impact, Dr. Goel has spearheaded the Nanobiosym Global Initiative, which is building innovative public-private partnerships with governments, NGO’s, academic, industrial and global thought leaders to help bring emerging technologies to address some of the world’s most pressing challenges.

For more information, please click here

Contacts:
Judith Light Feather
President
The NanoTechnology Group Inc.
Cell: 936-652-3006
www.TNTG.org
www.NanoNEWS.TV

Copyright © Nanobiosym

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Self-driving microrobots December 10th, 2019

CEA-Leti Thin-Film Batteries Target Extended Applications and Improved Performance in Medical Implants: IEDM 2019 Paper Reports Millimeter-Scale TFBs Exhibit the Best Performance In Both Energy and Power Densities December 10th, 2019

Arrowhead Pharmaceuticals Closes Underwritten Public Offering with Gross Proceeds of $266.8 Million December 7th, 2019

'Buildings' in human bone may hold key to stronger 3D-printed lightweight structures December 6th, 2019

Nanomedicine

Arrowhead Pharmaceuticals Closes Underwritten Public Offering with Gross Proceeds of $266.8 Million December 7th, 2019

Artificial cells act more like the real thing December 6th, 2019

Arrowhead Pharmaceuticals Announces Pricing of Underwritten Public Offering of Common Stock December 5th, 2019

Arrowhead Pharmaceuticals Announces Proposed Underwritten Offering of Common Stock December 3rd, 2019

Announcements

Self-driving microrobots December 10th, 2019

CEA-Leti Thin-Film Batteries Target Extended Applications and Improved Performance in Medical Implants: IEDM 2019 Paper Reports Millimeter-Scale TFBs Exhibit the Best Performance In Both Energy and Power Densities December 10th, 2019

Arrowhead Pharmaceuticals Closes Underwritten Public Offering with Gross Proceeds of $266.8 Million December 7th, 2019

'Buildings' in human bone may hold key to stronger 3D-printed lightweight structures December 6th, 2019

Environment

The Greenest Diet: Bacteria Switch to Eating Carbon Dioxide: Such bacteria may, in the future, contribute to new, carbon-efficient technologies November 27th, 2019

Research shows old newspapers can be used to grow carbon nanotubes: Newspapers provide a green, economical way to produce carbon nanotubes November 22nd, 2019

NAUM’19 reviewed the increasing contribution of graphene nanotubes to sustainable development November 21st, 2019

Argonne collaborates to review current battery recycling processes for electric vehicles November 8th, 2019

Energy

Graphene takes off in composites for planes and cars: The Graphene Flagship identified the strategic advantages of integrating graphene into fibre composites, used to build planes and cars December 5th, 2019

The Greenest Diet: Bacteria Switch to Eating Carbon Dioxide: Such bacteria may, in the future, contribute to new, carbon-efficient technologies November 27th, 2019

'Messy' production of perovskite material increases solar cell efficiency November 15th, 2019

Go with the flow: Scientists design new grid batteries for renewable energy: New blueprint for affordable, sustainable 'flow batteries' developed at Berkeley Lab could accelerate an electrical grid powered by the sun and wind November 8th, 2019

Events/Classes

"Inverse Design for Self-Assembly: Patchy Particles, Machine Learning, and the Truth about Entropy" December 3rd, 2019

Arrowhead Pharmaceuticals to Participate in Upcoming December 2019 Conferences November 26th, 2019

Arrowhead Pharmaceuticals Reports Fiscal Year 2019 Results November 25th, 2019

Onto Innovation to Participate in the 8th Annual NYC Investor Summit 2019 November 21st, 2019

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project